CareDx (CDNA) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CareDx, Inc. Reports First Quarter 2015 Financial Results
May 12, 2015 4:05 PM EDTQuarterly Revenue Growth of 22% Year Over Year
Cell-Free DNA Technology Advances With the Release of Clinical Data and the Start of a Clinical Trial
BRISBANE, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today reported financial results for the three months ended March 31, 2015.
2015 highlights year to date:
Total revenues for the first quarter... MoreCareDx, Inc. Reports First Quarter 2015 Financial Results
May 12, 2015 4:05 PM EDTQuarterly Revenue Growth of 22% Year Over Year
Cell-Free DNA Technology Advances With the Release of Clinical Data and the Start of a Clinical Trial
BRISBANE, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today reported financial results for the three months ended March 31, 2015.
2015 highlights year to date:
Total revenues for the first quarter... More